Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger BED domain-containing protein 3 (ZBED3) is a member of the ZBED family characterized by a zinc finger BED domain. It is primarily located in the cytoplasm, where it acts as a positive regulator of the canonical Wnt/β-catenin signaling pathway by directly interacting with Axin, thereby stabilizing cytoplasmic β-catenin and promoting transcription of Wnt target genes[3][5]. ZBED3 is involved in cell proliferation, cancer progression, metabolic regulation (including insulin resistance and diabetes), stem cell differentiation, and oocyte maturation. Loss of ZBED3 in model organisms leads to impaired cytoskeletal and organelle dynamics in early embryogenesis and reduced fertility[1][2][5]. Although it is not currently the direct target of therapeutic drugs, its central role in cell signaling and disease makes it a topic of significant research interest.
Disrupts recruitment of kinases required for β-catenin degradation by interacting with Axin; stabilizes β-catenin in cytoplasm, leading to canonical Wnt pathway activation. Phosphorylation-dependent interaction via PPPPSPT motif.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger BED domain-containing protein 3 (ZBED3).